Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC.

Cell Stem Cell. 2009 Mar 6;4(3):226-35. doi: 10.1016/j.stem.2009.01.007.

2.

ABCG2: the key to chemoresistance in cancer stem cells?

An Y, Ongkeko WM.

Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1529-42. doi: 10.1517/17425250903228834. Review.

PMID:
19708828
3.
4.

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Doyle L, Ross DD.

Oncogene. 2003 Oct 20;22(47):7340-58. Review.

PMID:
14576842
5.

ABCG2: determining its relevance in clinical drug resistance.

Robey RW, Polgar O, Deeken J, To KW, Bates SE.

Cancer Metastasis Rev. 2007 Mar;26(1):39-57. Review.

PMID:
17323127
6.

ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.

Ding XW, Wu JH, Jiang CP.

Life Sci. 2010 Apr 24;86(17-18):631-7. doi: 10.1016/j.lfs.2010.02.012. Epub 2010 Feb 14. Review.

PMID:
20159023
7.

The ABCG2 resistance network of glioblastoma.

Bleau AM, Huse JT, Holland EC.

Cell Cycle. 2009 Sep 15;8(18):2936-44. Epub 2009 Sep 13. Review.

PMID:
19713741
8.

Targeting the Akt-pathway to improve radiosensitivity in glioblastoma.

Narayan RS, Fedrigo CA, Stalpers LJ, Baumert BG, Sminia P.

Curr Pharm Des. 2013;19(5):951-7. Review.

PMID:
22973963
9.

PTEN, stem cells, and cancer stem cells.

Hill R, Wu H.

J Biol Chem. 2009 May 1;284(18):11755-9. doi: 10.1074/jbc.R800071200. Epub 2008 Dec 30. Review.

10.

Pancreatic cancer stem cells: fact or fiction?

Bhagwandin VJ, Shay JW.

Biochim Biophys Acta. 2009 Apr;1792(4):248-59. doi: 10.1016/j.bbadis.2009.02.007. Epub 2009 Feb 21. Review.

Supplemental Content

Support Center